Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • 30 Formulations...

30 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert

Written By : Dr. Divya Colin |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2024-07-24T18:00:19+05:30  |  Updated On 30 July 2024 11:53 AM IST
Drug Alert: CDSCO flags 56 formulations as Not of Standard Quality
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard Control Organisation (CDSCO), in its latest drug safety alert, has flagged 30 medicine batches for failing to qualify for a random sample test for June 2024

The list of drugs declared not of standard quality includes Liquid Paraffin manufactured by Kerala State Drugs and Pharmaceuticals, Losartan Potassium Tablets manufactured by Hindustan Antibiotics, Amloheart-AT [Amlodipine Besylate and Atenolol Tablets] manufactured by Lividus Pharmaceuticals, Bacotil-200 [Cefpodoxime Proxetil Tablets USP ] manufactured by Zenith Healthcare, Oseltamivir Supplied by Kerala Medical Services Corporation, Canditral 100 (itraconazole capsule B.P. 100 mg) manufactured by Glenmark Pharmaceuticals, Lytraco 200 Itraconazole Capsule manufactured by Sterlife Pharma, and others.

A number of factors contributed to the drug samples' failure in the test, such as non-compliance with the IP requirements for the particular drug, failure of the dissolution test, pH, and some assays of the drug test, among others.

Furthermore, the alert noted that NSQ data was not received as per Format and in EXCEL SHEET from State Drugs Licensing Authorities of Rajasthan (PDF format) and Orissa (PDF Format) for the Month of June 2024 as per DCG(I) Circular dated 09.02.2024.

In addition to the above, the alert mentioned, "State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh,Goa,Gujarat, Haryana, Himachal Pradesh, Manipur, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Sikkim, Tamil Nadu, Pondicherry,Telangana,Delhi,Uttarakhand, West Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of June, 2024 as per DCG(I) Circular dated 09.02.2024."

NOT OF STANDARD QUALITY ALERT FOR THE MONTH OF JUNE – 2024

B. State Laboratories

S.No

Product/Drug Name

Batch No.

Manufacturing Date

Expiry Date

Manufactured By

NSQ Result

Reported by CDSCO

Laboratory

1.

Liquid Paraffin IP

EP4032

01/24

12/26

Repacked by:- Kerala State Drugs and Pharmaceuticals Ltd, Kalavoor. P.O, Alappuzha

It fails the test of light absorption as per IP

Drugs Testing Laboratory Thiruvananthapuram

2.

Losartan Potassium Tablets IP 50 mg

HLOA06

11/23

10/25

Hindustan Antibiotics Ltd, at II, W.E.A.

Faridabad: 121 001(Haryana) R.O,

Pimpri, Pune -411 018

It fails the test ‘Dissolution’ as per IP

Drugs Testing Laboratory Thiruvananthapuram

3.

Amloheart-AT [Amlodipine Besylate and Atenolol Tablets]

LE223030

03/23

02/25

Lividus Pharmaceuticals pvt.Ltd, ikeva, Level2, Agnito Tech park,141 Kandachavadi, Near,

Perungudi, OMR, Chennai-600096

It fails the test ‘Assay’ of Amlodipine Besylate

Drugs Testing Laboratory Thiruvananthapuram

4.

Bacotil-200 [Cefpodoxime Proxetil Tablets USP ]

ZTB-148

03/24

02/26

Zenith Healthcare Ltd works: 388/34, Changodarlnd. Estate, Sarkhej Bavla Highway, Changodar- 382213

(Gujarat)

It fails the test ‘Dissolution’ as per USP

Drugs Testing Laboratory Thiruvananthapuram

5.

Oseltamivir Cap

IP 75 mg

D 0444/24-

25

Supplied by Kerala

Medical Services

The sample does not conform to IP

Drugs Testing

Laboratory

Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14

standard with respect to the ‘Descriptive part’

of hard gelatin capsules

Thiruvananthapuram

6.

Haridrakhandam

207/23

03/24

02/26

Bhaskaravilasam Vaidyasala, Panayamuttom, Nedumangadu Thiruvananthapuram 695

561

It fails the test ‘pH’ as per API

Drugs Testing Laboratory Thiruvananthapuram

7.

Yogarajaguggulu

209/21

03/22

3 yrs from the date of mfg

Bhaskaravilasam Vaidyasala, Panayamuttom, Nedumangadu, Thiruvananthapuram 695

561

It fails the test ‘Alcohol soluble Extractive and pH’ as per API

Drugs Testing Laboratory Thiruvananthapuram

8.

CANDITRAL 100 (ITRACONAZOLE CAPSULE B.P. 100 MG)

5230123

Jan-23

Jun-25

GLENMARK PHARMACEUTICALS LTD.

THE SAMPLE DOES NOT COMPLY WITH B P REQUIREMENTS FOR DISSOLUTION

TEST

Maharashtra

9.

Lytraco 200 Itraconazole Capsules 200 mg

SLP-22445

Feb-23

Jan-25

STERLIFE PHARMA PVT. LTD.

THE SAMPLE DOES NOT COMPLY WITH B P REQUIREMENTS FOR DISSOLUTION TEST THE SAMPLE IS OFFICIAL IN B P

2021 THEREFORE THE SAMPLE IS

Maharashtra

MISBRANDED VIDE SECTION 17(b) AND RULE

96 OF THE DRUGS AND COSMETICS ACT 1940 AND

RULES 1945.

10.

MONTOR -LC TABLET (MONTELUKAST SODIUM & LEVOCETRIZINE DIHYDROCHLORI

DE TABLET I.P.)

B18523001

Jan-23

Dec-24

TORQUE PHARMACEUTICALS PVT. LTD.

THE SAMPLE DOES NOT COMPLY WITH I P REQUIREMENTS FOR DISSOLUTION

TEST

Maharashtra

11.

MONTICET-L

Tablets

( Montelukast & Levocetirizine Hydrochloride Tablets)

TP-7581

Sep-22

Aug-24

TICOMA PHARMACIA

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR MONTELUKAST. THE SAMPLE IS OFFICIAL IN 1 P 2018 THEREFORE THE SAMPLE IS MISBRANDED VIDE SECTION 17(b) AND RULE

96 OF THE DRUGS AND COSMETICS ACT 1940 AND

RULES 1945.

Maharashtra

12.

Levocetrizine Dihydrochloride & Montelukast Sodium Tablets I.P. Zeemont

T22H370C

Aug-22

Jul-24

Bajaj Formulations

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR

DISSOLUTION

Maharashtra

TEST FOR MONTELUKAST.

13.

VolKast Kid Syrup 60 ml.

ABS- 2301022

Jan-23

Dec-24

Amentis Biotech Pvt. Ltd.

CONTENT OF MONTELUKAST AND LEVOCETIRIZINE GYDROCHLORIDE IN THE SAMPLE IS LESS (i.e.

MONTELUKAST IS 10.50% AND LEVOCETIRIZINE HYDROCHLORIDE IS 71.88% OF THE STATED AMOUNT) THAN THE

PERMISSIBLE LIMITS.

Maharashtra

14.

Levetiracetam Tablets U.S.P.500 Mg

(LEVEEG-500)

T23D050A

Apr-23

Mar-25

BAJAJ FORMULATIONS

THE SAMPLE DOES NOT COMPLY WITH USP REQUIREMENTS FOR

DISSOLUTION.

Maharashtra

15.

M2 Pan-DSR

(Pantoprazole Gastro-resistant & Domperidone Prolonged-release Capsules IP)

CWHC-283

Oct-22

Sep-24

COSWAY PHARMACEUTICALS

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION OF

PANTOPRAZOLE AT ACID STAGE

Maharashtra

16.

Omeford - 40

SNT-220421

Sep-22

Aug-24

SVR HEALTHCARE (A

GMP Certified Company)

THE CONTENT OF OMEPRAZOLE IN THE SAMPLE IS

LESS (l.e. 40.84% OF LABELLED

Maharashtra

AMOUNT) THAN THE SCHEDULE V LIMITS

17.

COZOL-

D(Omeprazole with Domperidone Capsules)

AC1952

Jul-23

Jun-25

ALICON PHARMACEUTICAL PVT LTD

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE).

THE SAMPLE IS OFFICIAL IN IP.

Maharashtra

18.

DRPLAN-DSR

(Pantoprazole Gasto-resistant & Domperidone Prolonged-release Capsules IP)

AC2209003A

Sep-22

Aug-24

ADDII BIOTECH PVT. LTD.

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR PANTOPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (PANTOPRAZOLE)

.

Maharashtra

19.

SOFTOM-D

Omeprazole and Domperidone Capsules IP

UD2C- 23252B

Apr-23

Mar-25

ULTRA DRUGS PVT. LTD. (UNIT-II)

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR

OMEPRAZOLE AND

Maharashtra

DOMPERIDONE CAPSULES FOR THE DISSOLUTION

TEST (OMEPRAZOLE).

20.

OMEPRAZOLE & DOMPERIDONE CAPSULES (REMIZOLE-D)

SPC230578 C

Mar-23

Feb-25

SALUS PHARMACEUTICALS

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION

TEST (OMEPRAZOLE).

Maharashtra

21.

PANTOPRAZOLE (EC) & DOMPERIDONE (SR) CAPSULES IP

(PANTIAC-DSR)

PTRC-149

Feb-23

Jan-25

IOSIS REMEDIES PVT. LTD.

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR PANTOPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (PANTOPRAZOLE)

.

Maharashtra

22.

DYNACID SUSPENSION

(aluminium, magnesium & simethicone oral

suspension IP.)

BULH23008

Apr-23

Mar-25

Leeford Healthcare Ltd.

1) THE SAMPLE DOES NOT COMPLY WITH I.P. REQUIREMENTS FOR TOTAL

AEROBIC VIABLE

Maharashtra

COUNT IN TEST FOR MICROBIAL CONTAMINATION.

2) TOTAL AEROBIC VIABLE COUNT OF THE SAMPLE IS 20993128 CFU/GM. (1.P. LIMIT-TOTAL AEROBIC VIABLE COUNT OF THE SAMPLE - NOT MORE THAN 100

CFU/GM

23.

ELTHROM-200

(Azithromycin oral suspension IP) 15ML

G-042/5045

May-23

Apr-25

ELFIN DRUGS PVT. LTD.

CONTENT OF AZITHROMYCIN IN THE SAMPLE IS LESS (72.96% OF LABELLED AMOUNT) THAN THE IP LIMIT WITH RESPECT TO ABOVE PROTOCOL. (IP LIMIT-90.0%-

110.0%)

Maharashtra

24.

Alpracan 0.5 Tablets (Alprazolam Tablets)

T2455

Oct-22

Sep-25

Evolet Pharmaceutical Pvt. Ltd.

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR ALPRAZOLAM TABLETS FOR THE DISSOLUTION TEST WITH RESPECT TO ABOVE

PROTOCOL.

Maharashtra

25.

RABEPP TABLETS

(Rabeprazole Sodium Tablets IP)

ATG2K135

Nov-22

Oct-24

ANROSE PHARMA

CONTENT OF RABEPRAZOLE SODIUM IM THE SAMPLE IS LESS (65.04% OF THE LABELLED AMOUNT) THAN THE IP LIMIT WITH RESPECT TO ABOVE PROTOCOL. (IP LIMIT 90.0% -

110.0%)

Maharashtra

26.

INFI-650 TABLETS (PARACETAMOL TABLETS I.P. 650

mg)

AT-100008

Dec-22

Nov-25

ABARIS HEALTHCARE

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION

TEST.

Maharashtra

27.

CUCID-DM

CDMC501

May-23

Apr-25

TULBROS FORMULATIONS

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR

OMEPRAZOLE IN ACID STAGE.

Maharashtra

28.

Virpan-40

T-2306031A

Jun-23

May-25

WHITE ENGLE LABORATORIES

THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION IN

BUFFER STAGE.

Maharashtra

29.

Pantakos-40 (Pantoprazole

CCT231092 B

Sep-23

Aug-25

Cent Cure Pvt Ltd.

THE SAMPLE DOES NOT

Maharashtra

Gastro-resistant Tablets IP )

COMPLY WITH IP REQUIREMENTS FOR

DISSOLUTION IN BUFFER STAGE.

30.

Rosumep ASP 10/75mg Capsules

PBWGM04

Sep-23

Aug-25

Pure & Care Healthcare Pvt. Ltd.

THE SAMPLE DOES NOT COMPLY WITH IP FOR THE TEST “RELATED

SUBSTANCES – ROSUVASTATIN”.

Maharashtra

To view the official notice, click the below link:

https://medicaldialogues.in/pdf_upload/state-nsq-alert-for-the-month-of-june-2024-245080.pdf

Also Read:CDSCO may waive cough syrups from testing for export to specific countries

drug alertnot of standard qualityglenmark-pharmaceuticalscdscohindustan antibioticscdsco alert
Dr. Divya Colin
Dr. Divya Colin

    Doctor of Pharmacy

    Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Health News Today

    Health Bulletin 08/ May/ 2025

    Health Bulletin 08/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok